Avid Bioservices (NASDAQ:CDMO – Get Free Report) and XOMA (NASDAQ:XOMAO – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk.
Profitability
This table compares Avid Bioservices and XOMA’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Avid Bioservices | -101.26% | -16.53% | -5.60% |
XOMA | N/A | N/A | N/A |
Analyst Ratings
This is a summary of current ratings for Avid Bioservices and XOMA, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Avid Bioservices | 0 | 1 | 4 | 0 | 2.80 |
XOMA | 0 | 0 | 0 | 0 | N/A |
Insider & Institutional Ownership
97.2% of Avid Bioservices shares are held by institutional investors. 2.4% of Avid Bioservices shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Valuation and Earnings
This table compares Avid Bioservices and XOMA”s revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Avid Bioservices | $142.36 million | 5.13 | -$140.75 million | ($2.21) | -5.20 |
XOMA | $9.81 million | N/A | N/A | N/A | N/A |
XOMA has lower revenue, but higher earnings than Avid Bioservices.
Summary
Avid Bioservices beats XOMA on 5 of the 8 factors compared between the two stocks.
About Avid Bioservices
Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is based in Tustin, California.
About XOMA
XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Receive News & Ratings for Avid Bioservices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avid Bioservices and related companies with MarketBeat.com's FREE daily email newsletter.